SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,933 | -55.6% | 198,288 | -3.7% | 0.00% | – |
Q2 2023 | $267,651 | -27.8% | 205,885 | -2.3% | 0.00% | – |
Q1 2023 | $370,894 | -45.5% | 210,735 | -2.7% | 0.00% | – |
Q4 2022 | $680,416 | -66.8% | 216,693 | -48.2% | 0.00% | -100.0% |
Q3 2022 | $2,051,000 | +188.5% | 418,562 | +242.0% | 0.00% | – |
Q1 2022 | $711,000 | -21.7% | 122,387 | +1.0% | 0.00% | – |
Q4 2021 | $908,000 | +82.7% | 121,133 | +119.7% | 0.00% | – |
Q3 2021 | $497,000 | – | 55,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |